JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32027

Anti-CBL 抗体 [YE323] - C-terminal

Anti-CBL antibody [YE323] - C-terminal

Be the first to review this product! Submit a review

|

(15 Publications)

Rabbit Recombinant Monoclonal CBL antibody. C-terminal. Suitable for ICC/IF, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 15 publications.

別名を表示する

CBL2, RNF55, CBL, E3 ubiquitin-protein ligase CBL, Casitas B-lineage lymphoma proto-oncogene, Proto-oncogene c-Cbl, RING finger protein 55, RING-type E3 ubiquitin transferase CBL, Signal transduction protein CBL

6 Images
Flow Cytometry (Intracellular) - Anti-CBL antibody [YE323] - C-terminal (AB32027)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-CBL antibody [YE323] - C-terminal (AB32027)

Intracellular Flow Cytometry analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling CBL with purified ab32027 at 1/30 dilution (10 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)
  • WB

Unknown

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)

All lanes:

Western blot - Anti-CBL antibody [YE323] - C-terminal (ab32027) at 1/1000 dilution

Lane 1:

Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 15 µg

Lane 2:

Rat testis lysate at 20 µg

Lane 3:

Rat thymus lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/2000 dilution

Predicted band size: 100 kDa

Observed band size: 110 kDa

false

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)
  • WB

Lab

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)

Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : CBL knockout HAP1 whole cell lysate (20 μg)
Lane 3 : THP1 whole cell lysate (20 μg)
Lane 4 : Raji whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab32027 observed at 100 kDa. Red - loading control, ab9484, observed at 37 kDa.

Unpurified ab32027 was shown to specifically react with CBL in wild-type HAP1 cells as signal was lost in CBL knockout cells. Wild-type and CBL knockout samples were subjected to SDS-PAGE. ab32027 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/5000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CBL antibody [YE323] - C-terminal (ab32027)

Predicted band size: 100 kDa

false

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)
  • WB

Lab

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)

Lanes 1-4 : Merged signal (red and green). Green - ab32027 observed at 110 kDa. Red - loading control ab8245 observed at 36 kDa.

Unpurified ab32027 Anti-CBL antibody [YE323] - C-terminal was shown to specifically react with CBL in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab267245 (knockout cell lysate ab257200) was used. Wild-type and CBL knockout samples were subjected to SDS-PAGE. ab32027 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CBL antibody [YE323] - C-terminal (ab32027) at 1/1000 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

CBL knockout HEK293T cell lysate at 20 µg

Lane 2:

Western blot - Human CBL knockout HEK-293T cell line (<a href='/products/cell-lines/human-cbl-knockout-hek-293t-cell-line-ab267245'>ab267245</a>)

Lane 3:

THP-1 cell lysate at 20 µg

Lane 4:

Raji cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 100 kDa

Observed band size: 110 kDa

false

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)
  • WB

Lab

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)

Western blot : Anti-CBL antibody [YE323] (ab32027) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab32027 was shown to bind specifically to CBL. A band was observed at 105 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in CBL knockout cell line. To generate this image, wild-type and CBL knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-CBL antibody [YE323] - C-terminal (ab32027) at 1/1000 dilution

Lane 1:

Wild-type HCT 116 cell lysate at 20 µg

Lane 2:

CBL knockout HCT 116 cell lysate at 20 µg

Lane 2:

Western blot - Human CBL knockout HCT116 cell line (<a href='/products/cell-lines/human-cbl-knockout-hct116-cell-line-ab287255'>ab287255</a>)

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 105 kDa

false

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)
  • WB

Lab

Western blot - Anti-CBL antibody [YE323] - C-terminal (AB32027)

Blocking and diluting buffer and concentration : 5% NFDM/TBST

Exposure time : 30 seconds

All lanes:

Western blot - Anti-CBL antibody [YE323] - C-terminal (ab32027) at 1/1000 dilution

Lane 1:

WEHI-231 (Mouse B cell lymphoma B lymphocyte) cell lysate at 10 µg

Lane 2:

F9 (Mouse embryonal carcinoma epithelial cell) cell lysate at 10 µg

Lane 3:

NIH/3T3 (Mouse embryonic fibroblast) cell lysate at 10 µg

Lane 4:

Mouse thymus lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 100 kDa

Observed band size: 110 kDa

false

関連する標識済み抗体及び組成の異なる製品 (2)

  • Carrier free

    Anti-CBL antibody [YE323] - BSA and Azide free

  • 578 PE

    PE Anti-CBL antibody [YE323] - C-terminal

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

YE323

アイソタイプ

IgG

キャリアフリー

No

交差種

Mouse, Rat, Human

アプリケーション

WB, ICC/IF, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

エピトープ

ab32027 reacts with an epitope located in the C terminal region of CBL.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p><strong>For unpurified use at 1/100</strong></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/5000</strong></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/30", "FlowCytIntra-species-notes": "<p>For unpurified use at 1/100 <a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p><strong>For unpurified use at 1/100</strong></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/5000</strong></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "1/30", "FlowCytIntra-species-notes": "<p>For unpurified use at 1/100 <a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Rat": { "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p><strong>For unpurified use at 1/100</strong></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified use at 1/5000</strong></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "1/30", "FlowCytIntra-species-notes": "<p>For unpurified use at 1/100 <a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Chicken": { "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Conditional Ambient
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The CBL protein also known as C-cbl or Casitas B-lineage lymphoma proto-oncogene serves as an E3 ubiquitin-protein ligase. This protein with a molecular mass of approximately 120-130 kDa plays a critical role in the regulation of receptor tyrosine kinases. It facilitates the polyubiquitination of activated receptor proteins targeting them for degradation in the proteasome. CBL is predominantly expressed in various tissues including the hematopoietic system. It is a significant component in the control of cell signaling and helps maintain cellular homeostasis.
Biological function summary

The CBL protein acts as a negative regulator for several signaling pathways. It integrates into signaling complexes and modulates the activation of pathways by interacting with other proteins. CBL does not act alone; it commonly forms complexes with proteins such as Grb2 and p85 influencing downstream signaling influence in pathways. This regulation prevents excessive activation of signals that can lead to cellular proliferation or differentiation abnormally.

Pathways

CBL integrates into the ubiquitin-proteasome system and the Ras signaling pathway. Within these pathways CBL works to modulate cell surface receptors ensuring that signaling threshold is not surpassed. The importance of CBL in the Ras signaling pathway is highlighted by its interactions with proteins like Ras-GAP and SHP2. Through these interactions CBL controls the rate of signal transduction affecting cellular responses such as growth survival and motility.

CBL involvement has been linked to several forms of cancer and immune deficiencies. Mutations or dysregulation of the CBL gene can lead to myelodysplastic syndromes and acute myeloid leukemia. In these conditions the interaction between CBL and other proteins such as JAK2 becomes dysregulated driving abnormal cell growth and survival. Furthermore CBL’s failure to properly degrade tyrosine kinase receptors can contribute to enhanced signaling fostering oncogenic processes.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

E3 ubiquitin-protein ligase that acts as a negative regulator of many signaling pathways by mediating ubiquitination of cell surface receptors (PubMed : 10514377, PubMed : 11896602, PubMed : 14661060, PubMed : 14739300, PubMed : 15190072, PubMed : 17509076, PubMed : 18374639, PubMed : 19689429, PubMed : 21596750, PubMed : 28381567, PubMed : 40101708). Accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome (PubMed : 10514377, PubMed : 14661060, PubMed : 14739300, PubMed : 17094949, PubMed : 17509076, PubMed : 17974561). Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, CSF1R, EPHA8 and KDR and mediates their ubiquitination to terminate signaling (PubMed : 15190072, PubMed : 18374639, PubMed : 21596750). Recognizes membrane-bound HCK, SRC and other kinases of the SRC family and mediates their ubiquitination and degradation (PubMed : 11896602). Ubiquitinates EGFR and SPRY2 (PubMed : 17094949, PubMed : 17974561). Involved in LAG3-mediated inhibition of TCR signaling : following ligand-binding to LAG3, catalyzes 'Lys-63'-linked ubiquitination of LAG3, unleashing the LAG3 C-terminus from the membrane, and initiating a signaling that prevents TCR activation (PubMed : 40101708). Ubiquitinates NECTIN1 following association between NECTIN1 and herpes simplex virus 1/HHV-1 envelope glycoprotein D, leading to NECTIN1 removal from cell surface (PubMed : 28381567). Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis (PubMed : 15190072, PubMed : 18374639). Essential for osteoclastic bone resorption (PubMed : 14739300). The 'Tyr-731' phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function (PubMed : 14739300). In association with CBLB, required for proper feedback inhibition of ciliary platelet-derived growth factor receptor-alpha (PDGFRA) signaling pathway via ubiquitination and internalization of PDGFRA (By similarity).
See full target information CBL

文献 (15)

Recent publications for all applications. Explore the full list and refine your search

Cellular and molecular life sciences : CMLS 82:149 PubMed40192802

2025

Circular RNA circSTX12 regulates osteo-adipogenic balance and proliferation of BMSCs in senile osteoporosis.

Applications

Unspecified application

Species

Unspecified reactive species

Huimin Gu,Wenhui Yu,Pei Feng,Chenying Zeng,Qian Cao,Fenglei Chen,Ziming Wang,Huiyong Shen,Yanfeng Wu,Shan Wang

Communications biology 7:1700 PubMed39725699

2024

MSC-derived exosomal circMYO9B accelerates diabetic wound healing by promoting angiogenesis through the hnRNPU/CBL/KDM1A/VEGFA axis.

Applications

Unspecified application

Species

Unspecified reactive species

Zheng Wang,Hongbo Xu,Bichen Xue,Lian Liu,Yulin Tang,Zhichao Wang,Kai Yao

Journal of oncology 2022:6093216 PubMed36618071

2022

Paeoniflorin Regulates NEDD4L/STAT3 Pathway to Induce Ferroptosis in Human Glioma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Xiao-Hu Nie,Sheng Qiu,Ying Xing,Jie Xu,Bin Lu,Shu-Fa Zhao,Yun-Tao Li,Zhong-Zhou Su

Technology in cancer research & treatment 20:15330338211045506 PubMed34817293

2021

CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiangdong Lu,Bin Zhou,Minmin Cao,Qin Shao,Yukai Pan,Tao Zhao

Journal of translational medicine 19:469 PubMed34798872

2021

Overexpression of E3 ubiquitin ligase Cbl attenuates endothelial dysfunction in diabetes mellitus by inhibiting the JAK2/STAT4 signaling and Runx3-mediated H3K4me3.

Applications

Unspecified application

Species

Unspecified reactive species

Qingsong Jin,Liangyan Lin,Tiantian Zhao,Xiaoyan Yao,Yaqin Teng,Dongdong Zhang,Yongjun Jin,Meizi Yang

Open life sciences 16:362-374 PubMed33954256

2021

circTLK1 facilitates the proliferation and metastasis of renal cell carcinoma by regulating miR-495-3p/CBL axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xiangli Lei,Meiling Yang,Zhifang Xiao,Heng Zhang,Shuai Tan

EBioMedicine 66:103290 PubMed33752128

2021

Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Guoxiang Xie,Runqiu Jiang,Xiaoning Wang,Ping Liu,Aihua Zhao,Yiran Wu,Fengjie Huang,Zhipeng Liu,Cynthia Rajani,Xiaojiao Zheng,Jiannan Qiu,Xiaoling Zhang,Suwen Zhao,Hua Bian,Xin Gao,Beicheng Sun,Wei Jia

Frontiers in oncology 11:566492 PubMed33791198

2021

MicroRNA-935 Directly Targets FZD6 to Inhibit the Proliferation of Human Glioblastoma and Correlate to Glioma Malignancy and Prognosis.

Applications

Unspecified application

Species

Unspecified reactive species

Dainan Zhang,Shunchang Ma,Chuanbao Zhang,Peiliang Li,Beibei Mao,Xiudong Guan,Wenjianlong Zhou,Jiayi Peng,Xi Wang,Shaomin Li,Wang Jia

Medical science monitor : international medical jo 25:8722-8732 PubMed31740654

2019

miR-652 Promotes Proliferation and Migration of Uveal Melanoma Cells by Targeting HOXA9.

Applications

Unspecified application

Species

Unspecified reactive species

Zhaoxia Xia,Chaoying Yang,Xiaoxi Yang,Shuduan Wu,Zhizhen Feng,Lei Qu,Xianghua Chen,Lingyu Liu,Yanling Ma

Journal for immunotherapy of cancer 7:284 PubMed31690351

2019

Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Minh Ngoc Duong,Efe Erdes,Michael Hebeisen,Nathalie Rufer
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com